Search News
| 1.50 Delayed Data As of 4:00pm ET |  +0.02 / +1.35%Today’s Change | 0.78 Today|||52-Week Range 3.75 | -36.44% Year-to-Date |
| Previous close | 1.48 |
| Today’s open | 1.47 |
| Day’s range | 1.44 - 1.54 |
| Volume | 79,355 |
| Average volume (3 months) | 534,050 |
| Market cap | $27.4M |
| Earnings growth (last year) | +86.71% |
| Earnings growth (this year) | +40.19% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +67.16% |
| P/E ratio | NM |
| Price/Sales | 42.25 |
| Price/Book | 3.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| PRTOProteon Therapeutics... | +0.10 | +4.26% |
| IMMPImmutep Ltd | +0.01 | +0.54% |
| FSIFlexible Solutions I... | -0.08 | -5.16% |
| HTGMHTG Molecular Diagno... | -0.10 | -2.87% |
| Next reporting date | May 10, 2018 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $911.0K |
| Annual profit (last year) | -$25.0M |
| Net profit margin | -2,739.74% |
Sector Health Technology |
Industry Biotechnology |
President, CEO & Head-Media Relations Michael V. Ward |
Chief Financial Officer James Clavijo |
Corporate headquarters Charleston, South Carolina |
